The price of Oscar Health Inc (NYSE:OSCR) shares last traded on Wall Street fell -0.34% to $20.41.
OSCR stock price is now 34.13% away from the 50-day moving average and 29.87% away from the 200-day moving average. The market capitalization of the company currently stands at $5.20B.
On March 13, 2025, Wells Fargo Downgraded its previous ‘Overweight’ rating to ‘Equal Weight’ on the stock reducing its target price from $20 to quote $16, while ‘Jefferies’ rates the stock as ‘Underperform’
In other news, RANMALI BOPITIYA, Officer bought 30,000 shares of the company’s stock on Jun 20 ’25. The stock was bought for $563,100 at an average price of $18.77. An SEC document containing details of the transaction can be found on the SEC’s website. On May 16 ’25, Former Officer ALESSANDREA QUANE bought 148,280 shares of the business’s stock. A total of $2,598,488 was incurred on buying the stock at an average price of $17.52. A total of 29.26% of the company’s stock is owned by insiders.
During the past 12 months, Oscar Health Inc has had a low of $11.20 and a high of $23.79. According to the stock market information, the enterprise value for the company is $2565636352, which is based on a 73.26 price-to-earnings ratio, a 0.47 price-to-earnings-growth ratio, and a beta of 1.84. The fifty day moving average price for OSCR is $15.217 and a two-hundred day moving average price translates $15.7152 for the stock.
The latest earnings results from Oscar Health Inc (NYSE: OSCR) was released for 2025-03-31. The net profit margin was 1.22% and return on equity was 10.43% for OSCR. The company reported revenue of $3.05 billion for the quarter, compared to $2.14 billion a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 42.2 percent.
